For one health system, staying the 340B drug program makes financial sense. Working at a large teaching hospital in Pennsylvania recently, I was able to ask the system CFO if he was thinking of giving up on the 340B program in light of the cuts. I was surprised by his…
Costs of outpatient versus inpatient knee replacement a clear area of contention in wake of report.  Last week seemed to be a quiet time on the Medicare regulatory front. Perhaps the three-day government shutdown resulted in things ramping back up, however. For a while I thought I’d have nothing to…
The OIG has added specialty drug coverage and reimbursement by Medicaid to its Work Plan.  In October, the OIG added specialty drug coverage and reimbursement by Medicaid to the list of active Work Plan items. This was in addition to the continuing Medicaid-related prescription drug reviews for the 2017 fiscal…